Sunvit-D3 Limited - Abbreviated accounts 16.3

REGISTERED NUMBER: 09082655 (England and Wales)

Abbreviated Unaudited Accounts for the Year Ended 30 June 2016

for

Sunvit-D3 Limited

Page

Abbreviated Balance Sheet

1

Notes to the Abbreviated Accounts

3

FIXED ASSETS

Intangible assets

2

120,000

135,000

Tangible assets

3

13,075

10,897

133,075

145,897

CURRENT ASSETS

Stocks

93,557

139,881

Debtors

105,329

109,327

Cash at bank and in hand

12,697

10,536

211,583

259,744

CREDITORS

Amounts falling due within one year

183,922

145,713

NET CURRENT ASSETS

27,661

114,031

TOTAL ASSETS LESS CURRENT
LIABILITIES

160,736

259,928

CREDITORS

Amounts falling due after more than one
year

195,055

337,115

NET LIABILITIES

(34,319

)

(77,187

)

CAPITAL AND RESERVES

Called up share capital

4

1

Profit and loss account

(34,320

)

(77,188

)

SHAREHOLDERS' FUNDS

(34,319

)

(77,187

)

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2016.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2016 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.

The financial statements were approved by the Board of Directors on 22 November 2016 and were signed on its behalf
by:

R O Allen - Director

1.	ACCOUNTING POLICIES

Accounting convention

The financial statements have been prepared under the historical cost convention and in accordance with the

Financial Reporting Standard for Smaller Entities (effective January 2015).

Exemption from preparing a cash flow statement

Exemption has been taken from preparing a cash flow statement on the grounds that the company qualifies as a

small company.

Turnover

Turnover represents the total invoice value, excluding value added tax, of sales made during the year.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 2014, is being amortised evenly over its estimated useful life of ten years.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow

moving items.

Going concern

The balance sheet at the end of the year recorded net liabilities. However, the director believes that sufficient

financial resources are available to the company to enable it to continue trading into the foreseeable future.

Therefore, the financial statements have been prepared on a going concern basis.

2.	INTANGIBLE FIXED ASSETS

Total

£

COST

At 1 July 2015

and 30 June 2016

150,000

AMORTISATION

At 1 July 2015

15,000

Amortisation for year

15,000

At 30 June 2016

30,000

NET BOOK VALUE

At 30 June 2016

120,000

At 30 June 2015

135,000

3.	TANGIBLE FIXED ASSETS

Total

£

COST

At 1 July 2015

15,912

Additions

6,085

At 30 June 2016

21,997

DEPRECIATION

At 1 July 2015

5,015

Charge for year

3,907

At 30 June 2016

8,922

NET BOOK VALUE

At 30 June 2016

13,075

At 30 June 2015

10,897

4.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2016

2015

value:

£

1

Ordinary

£1

1

5.	ULTIMATE PARENT COMPANY

ADAllen Pharma Limited is regarded by the directors as being the company's ultimate parent company.